Health Technology Assessment: Infliximab reference product versus biosimilar for the treatment of rheumatoid arthritis
At a glance
- Project team : Maria Carlander, Prof. Dr. Philipp Egli, Prof. Dr. Andreas Gerber-Grote, Cécile Grobet, Flurina Meier, Maxim Sharakin, Linda Vinci, Prof. Dr. Simon Wieser
- Project budget : CHF 165'000
- Project status : completed
- Funding partner : Federal government (Bundesamt für Gesundheit BAG / Sektion Health Technology Assessment (HTA))
- Contact person : Cécile Grobet